Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-498-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- fertility, other
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study according to actual guidelines conducted under GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia
- Molecular formula:
- Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia
- IUPAC Name:
- Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Octadecanoic acid, 9, 10-dihydroxy,
monoammonium salt due to composition renamed to Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia
- Molecular formula (if other than submission substance): C18H36O4H3N
- Molecular weight (if other than submission substance):333 g/mol
- Physical state: Viscous liquid, yellowish
- Analytical purity: see analytical report
- Composition of test material, percentage of components: purity approximately 50% in water
- Lot/batch No.: 0008050156
- Expiration date of the lot/batch:18 January 2013
- Storage condition of test material: ambient temperature
- Other: A report describing the characterization of the test item is included in Annex 4 (study 12L00047).
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RccHan: WIST strain, Harlan, Horst, The Netherlands
- Age at study initiation: 11-12 weeks
- Weight at study initiation: initial body weight variation did not exceed ±20% of the mean weight for each sex
- Housing: Animals were housed in macrolon cages with a bedding of wood shavings (Lignocel, Type ¾) and strips of paper (Enviro-dri) or a wooden block as environmental enrichment
- Use of restrainers for preventing ingestion (if dermal): yes/no
- Diet (e.g. ad libitum):ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: six days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 – 24°C (24.4ºC in one occasion during room cleaning)
- Humidity (%): relative humidity of at least 45% and not exceeding 65%
- Air changes (per hr): 10 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: tap water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dilutions of the test substance in the vehicle and the vehicle for dosing the controls were
prepared weekly (namely 27 April, 2, 10, 16, 23 and 30 May, 6 and 13 June 2012), and stored
in a refrigerator (2-10ºC), in portions sufficient for one day. A dosing volume of
5 mL/kg body weight was used for all groups. Dosing volume was adjusted based on the
latest body weight.
VEHICLE
- Amount of vehicle (if gavage): 5mL/kg bw
- Purity: tap water - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: Animals were caged together until mating occurred or 1 week had elapsed.
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- Sperm positive females that turn out to be non-pregnant were killed not earlier than 27 days after copulation.
- Further matings after two unsuccessful attempts: no
- After successful mating each pregnant female was caged (how): Upon evidence of copulation the females were caged individually for the birth and rearing of their pups. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- see annex V of report
Concentration was determined in samples from the batches prepared on 02 May 2012 and 30 May 2012. Homogeneity was determined in samples from 30 May 2012. The concentrations were determined according to a method validated in TNO Triskelion study 20139/01. - Duration of treatment / exposure:
- Male animals were dosed during a 2-week premating period, during mating and up to the day of sacrifice after the mating period. The female animals were dosed during a 2-week premating period, and during mating, gestation and lactation up to the day of sacrifice (approx. day 4 of lactation).
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
200mg/kg bw
Basis:
nominal conc.
(a.i. 50%, 100mg/kg bw a.i. )
- Remarks:
- Doses / Concentrations:
600mg/kg bw
Basis:
nominal conc.
(a.i. 50%, 300mg/kg bw a.i. )
- Remarks:
- Doses / Concentrations:
1000mg/kg bw
Basis:
nominal conc.
(a.i. 50%, 500mg/kg bw a.i. )
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: During 1-4 May 2012, the animals in the high-dose group received 2000 mg/kg (a.i. 1000mg/kg) body weight. Based on unscheduled deaths (females 81 and 87) and clinical signs the high-dose level was reduced to 1000 mg/kg body weight from 5
May 2012. - Positive control:
- none
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily in the morning and afternoon
- Cage side observations checked in table were included: All abnormalities, signs of ill health or reactions to treatment were recorded.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily in the morning
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights of male and female animals were recorded shortly before the start of
administration of the test item and at the start of the study. Males were weighed weekly until sacrifice Females were weighed once per week during the premating period. Mated females were weighed on days 0, 7, 14 and 21 during presumed gestation and on day 0 and 4 of lactation. Non-mated females were weighed once per week after the mating period. In addition, the animals were weighed on their scheduled necropsy date.
OTHER:
Food consumption
Food consumption was measured per cage over weekly intervals during the study, except for the mating period, during which no food consumption was registered. - Litter observations:
- At the end of the gestation period (GD 21), females were examined twice daily for signs of parturition. Any difficulties occurring during parturition were recorded. To keep nest disturbance to a minimum the litters were examined only once daily for dead pups.
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
- total litter size and numbers of each sex as well as the number of stillbirths, live- and dead pups and grossly malformed pups was evaluated on days 0 and 4 of lactation.
- pups were individually weighed on days 0 and 4 of lactation.
GROSS EXAMINATION OF DEAD PUPS:
yes, Grossly malformed pups were sacrificed and examined. A necropsy was performed on stillborn pups and pups dying during the study; macroscopic abnormalities were recorded. At necropsy of the dams, at day 4 of lactation, pups were examined externally for gross abnormalities and killed by freezing under CO2/O2 anaesthesia. - Postmortem examinations (parental animals):
- SACRIFICE
All surviving male and female parent animals were sacrificed by exsanguination from the abdominal aorta whilst under CO2/O2 anaesthesia at necropsy and then examined grossly for pathological changes. Male animals were sacrificed after the mating period. Female animals were sacrificed at or shortly after day 4 of lactation. A necropsy was also performed on animals that died or were killed intercurrently.
GROSS NECROPSY
- Gross necropsy performed
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated below were prepared for microscopic examination and weighed, respectively.
- ovaries (after counting the corpora lutea)
- oviduct
- uterus (after counting of the implantation sites, including cervix)
- vagina
- testes
- coagulation gland
- epididymes,
- seminal vesicles (including coagulation gland)
- prostate
- all gross lesions - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring were sacrificed at day 4 of lactation.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows: Grossly malformed pups were sacrificed and examined. A necropsy was performed on stillborn pups and pups dying during the study; macroscopic abnormalities were recorded
GROSS NECROPSY
- Gross necropsy performed
see litter observation - Statistics:
- Continuous data were subjected to a decision tree or parametric statistical test.
Dichotomous data were evaluated using the statistical test Chi-square-Fisher.
Tests were generally performed as twosided tests with results taken as significant where the probability of the results is p<0.05 (*) or p<0.01 (**). - Reproductive indices:
- The following parameters were calculated:
- pre-coital time = time between the start of mating and successful
copulation
- duration of gestation = time between gestation day 0 and day of
delivery
- female mating index = (number of females inseminated/number of females
placed with males) x 100
- male fertility index = number of males with pregnant females*100/number of
males placed with females
- female fertility index = number of pregnant females*100/number of inseminated
females
- gestation index = (number of females with live pups / number of
females pregnant) x 100
- live birth index = (number of pups born alive/number of pups born)
x 100
- viability index day 0 - 4 = (number of pup surviving 4 days/number of
liveborn on day 0) x100
- pup mortality day 0 or 4 = (number of dead pups on day 0 or 4/ total number
of pups on day 0 or 4) x 100
- sex ratio day 0 or 4 = (number of live male fetuses or pups on day 0 or
4/ number of live fetuses or pups on day 0 or 4)
x 100
- pre-implantation loss = [(number of corpora lutea – number of implantation sites)/number of
corpora lutea x 100
- number of los implantations = number of implantation sites – number of pups born alive
- post-implantation loss = [(number of implantation sites - number of pups
born alive)/ number of implantation sites] x 100. - Offspring viability indices:
- see reproductive indices
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- grunting respiration, mainly traced back to treatment methode (gavage)
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
Details on results (P0)
Clincal signs during experiment:
Two females of the high-dose group died. female 79 was found dead on day 13, female 95 was killed moribund on day 20. Several male and female rats showed a grunting respiration during the study. This was observed in 2 control males, 2 low-dose males, 5 mid-dose males + 4 mid-dose females and in 3 high-dose males + 6 high-dose females. This response generally occurred only occasionally during the premating, mating, gestation or the lactation period. In three rats (mid-dose female 55, high-dose male 80 and high-dose female 93) grunting respiration occurred more consistently during several days. This observation is considered to be related to the treatment method (oral gavage).
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- >= 500 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No treatment-related clinical signs were observed during lactation.
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- Macroscopic examination of the stillborn pup in the low-dose group showed no abnormalities for this pup
- Histopathological findings:
- not examined
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- >= 500 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Based on the absence of any signs of systemic toxicity in surviving rats, the No Observed
Adverse Effect Level (NOAEL) for parental toxicity is considered to be 1000 mg/kg bw/day test item (a.i. 500mg/kg bw/day). No treatment-related effects were observed on fertility and developmental parameters. Therefore, the NOAEL for fertility and development is established at the high-dose of 1000 mg/kg bw/day test item (a.i. 500mg/kg bw/day).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.